Editas Medicine Inc. , a genome editing company, opened at $18 in its debut on the Nasdaq Thursday. Editas sold 5.9 million shares at an issue price of $16, to raise $94.4 million. Shares were trading at $16.57 after the stock started trading. The company initially set a price range between $16 and $18 a share. Morgan Stanley and J.P. Morgan acted as the lead underwriters.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News